Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846141 | 12784614 | 1 | I | 20160316 | 20160920 | 20160927 | 20160927 | EXP | PHHY2016FR130639 | SANDOZ | 77.65 | YR | F | Y | 0.00000 | 20160927 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846141 | 12784614 | 1 | SS | ESIDREX | HYDROCHLOROTHIAZIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 127846141 | 12784614 | 2 | SS | ESIDREX | HYDROCHLOROTHIAZIDE | 1 | Oral | 0.5 DF, UNK | 0 | .5 | DF | TABLET | |||||||
| 127846141 | 12784614 | 3 | PS | SOTALOL. | SOTALOL | 1 | Oral | 1 DF, BID (IN THE MORNING AND IN THE EVENING) | Y | 75366 | 1 | DF | BID | ||||||
| 127846141 | 12784614 | 4 | SS | RAMIPRIL. | RAMIPRIL | 1 | Oral | QD (IN THE EVENING) | 0 | QD | |||||||||
| 127846141 | 12784614 | 5 | SS | RAMIPRIL. | RAMIPRIL | 1 | Oral | 1.25 MG | 0 | 1.25 | MG | ||||||||
| 127846141 | 12784614 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | UNK | U | 0 | |||||||||
| 127846141 | 12784614 | 7 | C | PREVISCAN | FLUINDIONE | 1 | Oral | 1.25 DF, QD | U | 0 | 1.25 | DF | TABLET | QD | |||||
| 127846141 | 12784614 | 8 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 20 MG, QD IN THE EVENING | U | 0 | 20 | MG | QD | ||||||
| 127846141 | 12784614 | 9 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 1 DF, BID (IN THE MORNING AND IN THE EVENING) | U | 0 | 1 | DF | FILM-COATED TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127846141 | 12784614 | 1 | Hypertension |
| 127846141 | 12784614 | 3 | Atrial fibrillation |
| 127846141 | 12784614 | 4 | Ischaemic stroke |
| 127846141 | 12784614 | 6 | Hypertension |
| 127846141 | 12784614 | 7 | Atrial fibrillation |
| 127846141 | 12784614 | 8 | Dyslipidaemia |
| 127846141 | 12784614 | 9 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127846141 | 12784614 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127846141 | 12784614 | Acute kidney injury | |
| 127846141 | 12784614 | Atrioventricular block complete | |
| 127846141 | 12784614 | Bradycardia | |
| 127846141 | 12784614 | Hyperkalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127846141 | 12784614 | 1 | 20160316 | 20160316 | 0 | |
| 127846141 | 12784614 | 2 | 20160318 | 0 | ||
| 127846141 | 12784614 | 3 | 201505 | 20160316 | 0 | |
| 127846141 | 12784614 | 4 | 20160316 | 0 | ||
| 127846141 | 12784614 | 5 | 20160318 | 0 | ||
| 127846141 | 12784614 | 7 | 201505 | 0 |